Free tool
Oncology stocks
We cover 2 companies grouped under the Oncology theme. The median market value in the group is $398.30M. Across the group, the median move over the past trading day is +1.33%. Price change over the past year runs from +20.9% to +481.9% across the middle 80 percent of the group, with a median of +251.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 4588.T | Oncolys BioPharma Inc. | 4,080.00 JPY | +66.46% | +173.09% | +539.50% |
| 4583.T | Chiome Bioscience Inc. | 86.00 JPY | +26.47% | −19.63% | −36.76% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.